Suppression of kinesin family member-18A diminishes progression and induces apoptotic cell death of gemcitabine-resistant cholangiocarcinoma cells by modulating PI3K/Akt/mTOR and NF-κB pathways
PLOS One · 2025
DOI: 10.1371/journal.pone.0334147 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Pakornkiat Tanasuka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Kinesins, Deoxycytidine, Cholangiocarcinoma, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science, Research and Innovation Fund (NSRF), Thailand through the Fundamental Fund of Khon Kaen University, Postgraduate Study Scholarship from Faculty of Medicine, Khon Kaen University, Thailand.
Abstract (Originalsprache)
Cholangiocarcinoma (CCA), particularly when associated with Opisthorchis viverrini infection, is often diagnosed at a late stage and exhibits high resistance to chemotherapy, notably gemcitabine. While kinesin family member 18A (KIF18A) is upregulated in opisthorchiasis-associated CCA, its precise function, especially in gemcitabine-resistant CCA, remains largely unexplored. Herein, expression of KIF18A in relation to survival and progression was assayed by TCGA database mining and immunohistochemistry of a tissue microarray derived from 84 CCA patients. For functional study, KIF18A was suppressed in gemcitabine-resistant CCA cells (KKU-213B GemR ) using a CRISPR/Cas9 technique, followed by cellular and molecular analyses. Our results showed that KIF18A was highly expressed in CCA tissues compared to normal counterparts. Its expression was significantly correlated with tumor size and histological type of CCA but not with overall survival time. In vitro , KIF18A expression levels were increased in CCA cell lines, particularly KKU-213B GemR . Suppression of KIF18A significantly inhibited colony formation, migration and invasion by KKU-213B GemR cells. In addition, KIF18A knockdown led to a significant increase in the sub-G1 population, indicating the occurrence of cellular apoptosis. Flow cytometry confirmed that suppression of KIF18A significantly induced early apoptotic cell death of KKU-213B GemR cells. Suppression of KIF18A dramatically downregulated the expression of key oncogenic and survival signaling proteins, including PI3K (total and p-PI3K), Akt (total and p-Akt), mTOR (total and p-mTOR), NF-κB (total and p-NF-κB) and Bcl-2 in KKU-213B GemR cells. Taken together, our findings suggest that KIF18A plays crucial roles in promoting the progression and survival of gemcitabine-resistant CCA cells, partly by modulating PI3K/Akt/mTOR and NF-κB pathways. Therefore, despite its lack of prognostic utility, KIF18A represents a promising therapeutic target for improving treatment outcomes in CCA patients, especially those who do not respond to gemcitabine treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand.
- Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
- Biomedical Sciences Program, Graduate School, Khon Kaen University, Khon Kaen, Thailand.
- National Phenome Institute, Office of the President, Khon Kaen University, Khon Kaen, Thailand.
ORCID-Profile: Pakornkiat Tanasuka, Suppakrit Kongsintaweesuk, Sasithorn Watcharadetwittaya, Kitti Intuyod
Förderung
- National Science, Research and Innovation Fund (NSRF), Thailand through the Fundamental Fund of Khon Kaen University
- Postgraduate Study Scholarship from Faculty of Medicine, Khon Kaen University, Thailand
Zitieren
APA
Tanasuka, P., Thongpon, P., Chomwong, S., Kongsintaweesuk, S., Pinlaor, S., Pongking, T., Watcharadetwittaya, S., Pairojkul, C., & Intuyod, K. (2025). Suppression of kinesin family member-18A diminishes progression and induces apoptotic cell death of gemcitabine-resistant cholangiocarcinoma cells by modulating PI3K/Akt/mTOR and NF-κB pathways. PLOS One. https://doi.org/10.1371/journal.pone.0334147
Vancouver
Tanasuka P, Thongpon P, Chomwong S, Kongsintaweesuk S, Pinlaor S, Pongking T, et al. Suppression of kinesin family member-18A diminishes progression and induces apoptotic cell death of gemcitabine-resistant cholangiocarcinoma cells by modulating PI3K/Akt/mTOR and NF-κB pathways. PLOS One. 2025. doi:10.1371/journal.pone.0334147
BibTeX
@article{Tanasuka2025,
author = {Tanasuka, Pakornkiat and Thongpon, Phonpilas and Chomwong, Sasitorn and Kongsintaweesuk, Suppakrit and Pinlaor, Somchai and Pongking, Thatsanapong and Watcharadetwittaya, Sasithorn and Pairojkul, Chawalit and Intuyod, Kitti},
title = {Suppression of kinesin family member-18A diminishes progression and induces apoptotic cell death of gemcitabine-resistant cholangiocarcinoma cells by modulating PI3K/Akt/mTOR and NF-κB pathways},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0334147}
}
EUVIMED